132 related articles for article (PubMed ID: 2129301)
1. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
Tsuchiya H; Onishi T; Mogami H; Iida M
Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
[TBL] [Abstract][Full Text] [Related]
2. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
3. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
5. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.
Oscarsson J; Wiklund O; Jakobsson KE; Petruson B; Bengtsson BA
Clin Endocrinol (Oxf); 1994 Nov; 41(5):603-8. PubMed ID: 7828349
[TBL] [Abstract][Full Text] [Related]
7. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
8. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
9. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
10. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
11. The results of transsphenoidal surgery for 44 consecutive acromegalic patients.
Yamada S; Takada K; Ozawa Y; Shimizu T; Sawano S; Shishiba Y; Sano T; Usui M
Endocr J; 1997 Jun; 44(3):395-402. PubMed ID: 9279515
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin-C in active and successfully treated acromegaly.
Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
[TBL] [Abstract][Full Text] [Related]
14. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
15. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
[TBL] [Abstract][Full Text] [Related]
17. Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.
Roelfsema F; Frölich M
Clin Endocrinol (Oxf); 1985 Apr; 22(4):531-7. PubMed ID: 3886210
[TBL] [Abstract][Full Text] [Related]
18. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
19. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]